<DOC>
	<DOC>NCT00741520</DOC>
	<brief_summary>Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension. However, there are few data regarding the impact of OSA on the preHypertension and Masked Hypertension in apparently normotensive patients with OSA as well as the impact of treatment with continuous positive airway pressure.</brief_summary>
	<brief_title>Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Severe OSA patients Smoking Sustained Hypertension Heart failure Diabetes Renal diseases Under use of any medication Under treatment for OSA</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>PreHypertension</keyword>
	<keyword>Masked Hypertension</keyword>
</DOC>